Skip to content

A brief acceptance and mindfulness intervention for exercise in anxiety: Study protocol for a randomized controlled trial

Emily Carl

preprint DOI: 10.31234/osf.io/ahvcx (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial
Sample size 120
Population Individuals with elevated anxiety symptoms
Intervention mindfulness and acceptance intervention
Duration One week follow-up
Topics Anxiety Meditation
Key findings Proposes that a single-session mindfulness and acceptance intervention will increase exercise behavior and physical activity among individuals with elevated anxiety symptoms, with anxiety sensitivity as a potential mediator.

Abstract

Physical exercise shows ameliorative effects on anxiety symptoms. Only about half of individuals in the United States meet recommended physical activity levels, and those with anxiety show even lower levels. One barrier to exercise among individuals with anxiety is anxiety sensitivity, which is the belief that anxiety and sensations that mimic symptoms of anxiety have harmful consequences. This study will test whether a single session of a mindfulness and acceptance intervention can increase exercise behavior and physical activity among individuals with elevated anxiety symptoms. We will randomize 120 individuals to the mindfulness intervention or inactive control condition. An immediate behavioral outcome measured by time exercised in the lab will assess efficacy of mindfulness, as well as physical activity and psychological outcomes one week later. In addition, we will test whether anxiety sensitivity mediates the effect of mindfulness on physical activity. If the mindfulness intervention is effective, it would provide a way to increase the use of exercise as an accessible and effective way to manage elevated anxiety.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Explore topics